Home
Scholarly Works
OCELOT: A Pan-Canadian Study of Osimertinib for...
Conference

OCELOT: A Pan-Canadian Study of Osimertinib for Patients with Treatment Naive Advanced NSCLC with Uncommon EGFR Mutations

Authors

Breadner D; Liu G; Wheatley-Price P; Menjak I; Wang Y; Rothenstein J; Valdes M; Bains P; Juergens R; Cheema P

Volume

20

Publisher

ELSEVIER SCIENCE INC

Publication Date

October 1, 2025

Conference proceedings

JOURNAL OF THORACIC ONCOLOGY

Issue

10

ISSN

1556-0864

Contact the Experts team